COLOPLAST A/S/ADR (OTCMKTS:CLPBY) Sets New 12-Month High at $11.51

COLOPLAST A/S/ADR (OTCMKTS:CLPBY)’s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as $11.51 and last traded at $11.48, with a volume of 4127 shares changing hands. The stock had previously closed at $11.39.

Several equities analysts recently issued reports on CLPBY shares. Zacks Investment Research lowered COLOPLAST A/S/ADR from a “hold” rating to a “sell” rating in a research report on Tuesday, March 12th. ValuEngine upgraded COLOPLAST A/S/ADR from a “hold” rating to a “buy” rating in a research report on Thursday, February 28th.

The stock has a 50-day moving average of $10.98. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 0.01. The company has a market cap of $24.21 billion, a price-to-earnings ratio of 38.66 and a beta of 0.51.

COLOPLAST A/S/ADR (OTCMKTS:CLPBY) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $0.07 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.07. COLOPLAST A/S/ADR had a return on equity of 70.05% and a net margin of 23.28%. The business had revenue of $688.45 million for the quarter.


Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit to individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.

Read More: Economic Reports

Receive News & Ratings for COLOPLAST A/S/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COLOPLAST A/S/ADR and related companies with's FREE daily email newsletter.